About Vapotherm
Vapotherm high-velocity therapy is mask-free non-invasive respiratory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The HVT 2.0 and Precision Flow systems’ mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.

- HYPERACT Trial Published: A Paradigm Shift in Respiratory CareThe publication of “High-Velocity Nasal Insufflation vs Non-Invasive Positive Pressure Ventilation for Moderate Acute Exacerbation of COPD in the ED”
- Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADEDr. Jessica Whittle, Chief Medical Officer of Vapotherm, emphasized the company’s commitment to improving the lives of hypercapnic patients in the home. “Our mission is to improve quality of life and reduce hospital readmissions for patients who struggle with respiratory disease. Access365 will provide optimal treatment at home, especially for COPD patients, by combining the known benefits of nocturnal NIV with the comfort of high velocity therapy for daytime use.”
- Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT) Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and device management goals for HVT® 2.0 and future Home system
Meet our Executive Committee
Joseph Army President & Chief Executive Officer
Joseph Army has served as President, Chief Executive Officer and as a member of the board of directors of Vapotherm since June 2012. Prior to joining Vapotherm, Mr. Army served as President and Chief Executive Officer of Salient Surgical Technologies, Inc. (formerly TissueLink Medical, Inc.), or Salient, since 2007. He first joined Salient in 1999 as Chief Financial Officer and Vice President of Finance. Prior to his time at Salient, he held various positions including Vice President of Finance and Supply Chain Operations for Westaim Biomedical from 1998 to 1999 and strategy consultant for Coopers & Lybrand LLP from 1991 to 1997. Mr. Army holds an MBA in finance from The Wharton School and a BA in history from the University of Rhode Island. He is certified in production and inventory management and is a certified public accountant (inactive status). We believe Mr. Army’s knowledge of the Vapotherm business and his leadership experience at other organizations qualified him to serve on our board of directors.
John Landry Senior Vice President & Chief Financial Officer
John Landry has served as Senior Vice President and Chief Financial Officer, Secretary and Treasurer since August 2012. Prior to joining Vapotherm, he held a number of leadership roles at Salient from 2004 to 2011, including VP Accounting & Controller and VP Global Business Development. Mr. Landry also served as Director of International Marketing at Medtronic Advanced Energy from 2011 to 2012, which acquired Salient in August 2011. Prior to his time at Salient, he served in various financial leadership roles at Bottomline Technologies from 2000 to 2004, Hussey Seating Company from 1997 to 2000 and Coopers & Lybrand LLP from 1994 to 2000. Mr. Landry graduated summa cum laude from Bentley College with a BS in Accountancy and is a certified public accountant (inactive status).
Lindsay Becker Vice President, Human Resources
Lindsay Becker joined Vapotherm in July 2012 and has served as Vice President, Human Resources since January 2018. Previously, she served as our Director of Human Resources from January 2015 to December 2017, Human Resources Manager from April 2013 to December 2014 and Executive Assistant to the CEO from July 2012 to March 2013. From 2011 to 2012, she served as an Account Executive for a digital marketing firm, SilverTech. From 2007 to 2011 she worked in the Office of Governor John Lynch as Citizens Services Representative, Director of Scheduling and Executive Assistant. Ms. Becker graduated summa cum laude from Saint Anselm College with a BA in history.
James Lightman Senior Vice President and General Counsel
James Lightman has served as Vapotherm’s senior vice president, general counsel and secretary since December, 2020. Mr. Lightman brings to Vapotherm over two decades of corporate legal experience and a diverse skill set in managing complex legal and business matters for public and private healthcare and medical device companies. He has held chief legal officer positions with leading healthcare technology companies including Eyeonics, Inc., IntraLase Corp., Summit Autonomous Inc., Amicore, Inc. and Wright Medical Group, N.V. From 2008 to 2009, Mr. Lightman served as Vice President and Assistant General Counsel at Bausch & Lomb, where he most recently held the position of Vice President, Global Sales Operations until 2011. In 2011, Mr. Lightman joined Wright Medical Group, Inc. as Senior Vice President, General Counsel and Secretary, a position he held until November, 2020, when Wright was acquired by Stryker Corp. Mr. Lightman holds a juris doctor degree cum laude from the Boston University School of Law and a bachelor’s degree magna cum laude from the Boston University School of Management. He is a member of the Massachusetts Bar.
Brian Lawrence Senior Vice President and Chief Technology Officer
Brian Lawrence joined Vapotherm in December 2021 as Senior Vice President and Chief Technology Officer. Prior to joining Vapotherm, Mr. Lawrence, age 52, served as Chief Technology Officer & General Manager of Gravity Diagnostics, LLC, a diagnostics company, where he was responsible for technology and innovation programs across the company. Prior to joining Gravity Diagnostics, Mr. Lawrence served as Senior Vice President & Chief Technology Officer of Hillrom Holdings, Inc. (“Hillrom”), a medical device company, from 2010 to 2021. While at Hillrom, Mr. Lawrence was responsible for global technology and innovation teams of over 800 employees in seven countries and an annual budget of $150 million. He led a digital transformation for the company and created a new SaaS business valued at over $100 million. Prior to that position, he served as Chief Technology Officer of Life Support Solutions, a division of GE Healthcare, where he was responsible for global engineering teams of over 400 employees across the US, Europe, and Asia with a budget of over $70 million annually. Mr. Lawrence holds a Doctor of Philosophy, Electrical Engineering, from the Center for Research and Education in Optics and Lasers (CREOL), University of Central Florida, and a Master of Science, Electrical Engineering and a Bachelor of Science, Electrical Engineering from Massachusetts Institute of Technology.
Jessica Whittle Chief Medical Officer and VP of Clinical Research
Dr. Whittle MD, PhD joined Vapotherm in February of 2022 as the VP of Clinical Research and was promoted to Chief Medical Officer in January 2023. She is a Professor and Vice Chair of Research for the Department of Emergency Medicine at the University of Tennessee – Chattanooga/ Erlanger Health System. She lectures both nationally and internationally on respiratory support and critical care and has been a featured guest on prominent EM podcasts, including EM:RAP and ACEP FrontLine. Dr. Whittle was a contributing author to the ACEP Field Guide to COVID-19 which has been reproduced in 6 languages and more than 120 countries. She has authored 60+ peer-reviewed manuscripts and abstracts.
Dr. Whittle received her undergraduate degree at Appalachian State University, her Ph.D. in Immunology and Molecular Pathogenesis from Emory University, and her MD degree from the University of Alabama School of Medicine. Her EM Residency training was completed at Orlando Regional Hospital, Orlando, FL.
Compliance Program & Declaration
Code of Business Conduct
Vapotherm, Inc is committed to ensuring that its business practices are conducted in an ethical and transparent manner and in compliance with all applicable laws, including the California Health and Safety Code §119400-119402 (the “California Code”).
Vapotherm, Inc has developed a Comprehensive Compliance Program, consistent with HHS-OIG guidance and in accordance with the AdvaMed Code of Ethics on Interactions with Health Care Professionals, a voluntary ethical code specifically tailored for the unique interactions between the medical technology industry and our health care professional partners. This program is reasonably designed to prevent and detect violations and meet the goals set forth by the State of California.
Compliance Declaration
As of June 17, 2024, to the best of its knowledge and based on a good faith understanding of the requirements of the California Code, Vapotherm, Inc declares that it is in compliance with its Comprehensive Compliance Program and the California Code.
For a copy of our compliance program please call +1(603)-658-0011.
Our
Story
We Do Work That Matters.
Open
Positions
Join the Vapotherm Team.
Contact Us
We’re Here To Help.
Learn More?
Request a demo and we’re happy to connect you with a team member!
CAUTION: US Federal law restricts this device to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at https://vapotherm.com/resources/support/precision-flow-reference/. For spontaneously breathing patients. High Velocity Therapy (HVT) does not provide total ventilatory requirements of the patient. It is not a ventilator. Decisions surrounding patient care depend on the physician’s professional judgment in consideration of all available information for the individual case, including escalation of care depending on patient condition.